Genomic-data privacy platforms

01Overview and value chain#

Markers EC: Federated & privacy-preserving genomic-data analysis platforms | OECD: Bioeconomy policy & governance | Regulator: FTC (US), EDPB (EU)

Genomic-data privacy platforms are a B2B services category providing the technical infrastructure that lets researchers, clinicians and biopharma partners analyze sensitive genomic and health data without moving or exposing the underlying records. Duality Technologies runs a secure-computation platform used for Genome-Wide Association Studies, letting researchers compute sensitive statistics across siloed datasets without moving data or compromising privacy, security or compliance. TripleBlind, now integrated into Selfii’s privacy-preserving health-data business, launched the TripleBlind Exchange, a first-of-its-kind marketplace for secure data transactions in healthcare. Lifebit, pioneer of the federated Trusted Research Environment (TRE) architecture, lets researchers turn genomic data into insights without the data ever leaving its source, preserving data sovereignty. Privitar holds a granted 2026 US patent for a computer-implemented privacy-engineering system and method, reflecting its core data-anonymization and privacy-engineering technology base. Aridhia introduced an AI Research Assistant Framework in 2026 for secure AI use over sensitive patient records, clinical trials and genomic datasets within its Trusted/Secure Research Environment offering.

The key directions of genomic-data privacy platforms are:

1. Federated trusted research environments: secure platforms where researchers analyze sensitive genomic data in place, without the data ever leaving its source institution.
2. Homomorphic-encryption-based secure computation: cryptographic techniques allowing statistical computation directly on encrypted genomic data across siloed datasets.
3. Privacy-preserving data marketplaces: infrastructure enabling secure, compliant data transactions between genomic-data holders and researchers or biopharma buyers.
4. AI-assisted secure research tooling: AI research-assistant tools layered on top of trusted research environments to accelerate analysis while preserving the underlying data-governance controls.

Sectoral value chain#

[Data-holder onboarding & governance setup] ──> [Secure environment provisioning] ──> [Query/analysis request]
                                                                        │
                                                            (Privacy-preserving computation)
                                                                        │
              [Result delivery to requester] <──── [Output disclosure control review] <─── [Result generation]

Value chain levels#

Cross-cutting technologies of the sector:

• Federated trusted research environments: secure platforms enabling analysis of sensitive genomic data in place, without the underlying data ever leaving its source institution.
• Homomorphic-encryption genomic analysis: cryptographic computation directly on encrypted genomic data, enabling statistical analysis across siloed datasets without decryption.
• Privacy-preserving data marketplaces: infrastructure enabling secure, compliant, auditable data transactions between genomic-data holders and researchers or biopharma buyers.

02US#

The United States hosts specialist cryptography and data-marketplace platforms applying advanced privacy-preserving computation techniques specifically to genomic and health-data research use cases.

Duality Technologies’ secure-computation platform, TripleBlind Exchange’s data marketplace#

• Duality Technologies: runs a secure-computation platform used for Genome-Wide Association Studies, letting researchers compute sensitive statistics across siloed datasets without moving data or compromising privacy, security or compliance.
• TripleBlind: now integrated into Selfii’s privacy-preserving health-data business, launched the TripleBlind Exchange, a first-of-its-kind marketplace for secure data transactions in healthcare.

03CN#

China is covered qualitatively rather than through a live-screened Chinese vendor: candidate Chinese genomic-data-privacy platforms searched during this screen returned no confirming 2026 source specific to this service category.

No China-headquartered vendor confirmed in this screen#

• Search outcome: two candidate Chinese firms were searched during this screen and neither returned a confirming live 2026 source for this specific service category.
• Market structure: China’s large genomic-sequencing operators hold substantial genomic datasets domestically, but no confirmed China-headquartered vendor specializing in privacy-preserving genomic-data computation infrastructure was found in this screen.

04EU#

Europe, and the UK specifically, hosts pioneers of the federated Trusted Research Environment model alongside data-privacy-engineering and secure-research-environment specialists.

Lifebit’s federated TRE architecture, Privitar’s privacy-engineering patents, Aridhia’s secure research environments#

• Lifebit: headquartered in the UK, pioneer of the federated Trusted Research Environment (TRE) architecture, lets researchers turn genomic data into insights without the data ever leaving its source.
• Privitar: headquartered in the UK, holds a granted 2026 US patent for a computer-implemented privacy-engineering system and method, reflecting its core data-anonymization technology base.
• Aridhia: headquartered in the UK, introduced an AI Research Assistant Framework in 2026 for secure AI use over sensitive patient records, clinical trials and genomic datasets within its Trusted/Secure Research Environment offering.

05Leading companies and research institutes#

06Tech stack and innovations#

The genomic-data privacy platform technology stack combines federated computation, cryptographic techniques and AI-assisted research tooling to enable analysis without data movement:

1. Federated computation without data movement:
   • Lifebit’s federated TRE architecture and Duality’s secure federated AI collaboration both let researchers compute across siloed datasets while the underlying genomic records never leave their source institution.
2. Cryptographic privacy engineering:
   • Privitar’s granted 2026 US patent for a computer-implemented privacy-engineering system reflects the underlying anonymization and re-identification-risk-control technology this category depends on.
3. AI-assisted secure research environments:
   • Aridhia’s 2026 AI Research Assistant Framework layers AI tooling on top of its Trusted Research Environment, accelerating analysis while preserving the same data-governance controls.

07Value chains and production pipelines#

Industrial pipeline for a privacy-preserving genomic-data analysis request#

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Data-holder onboarding & │ ───> │ 2. Secure environment       │
│    governance setup              │      │    provisioning                   │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Privacy-preserving       │ <─── │ 3. Query/analysis           │
│    computation                   │      │    request                        │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Result generation &      │ ───> │ 6. Result delivery            │
│    disclosure control review     │      │    to requester                   │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Data-holder onboarding and governance setup

A genomic-data holder — biobank, hospital, research institution — is onboarded and data-governance rules are configured.

Stage 2: Secure environment provisioning

The federated or encrypted secure environment in which analysis will occur is provisioned.

Stage 3: Query/analysis request

A researcher or biopharma partner submits a query or analysis request against the governed dataset.

Stage 4: Privacy-preserving computation

The query is executed using federated computation, homomorphic encryption or equivalent privacy-preserving methods, without exposing raw records.

Stage 5: Result generation and disclosure control review

The computed result is reviewed against disclosure-control rules to ensure no re-identification risk before release.

Stage 6: Result delivery to requester

The disclosure-reviewed result is delivered to the requesting researcher or biopharma partner.